Diagnostic Products Archives

Cat #: 91210047

LymphoTrack^® Dx IGH FR3 Assay – S5/PGM™

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210109

LymphoTrack^® Dx IGH FR3 Assay Kit A – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210089

LymphoTrack^® Dx IGH FR2 Assay Kit A – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210139

LymphoTrack^® Dx IGH FR1/2/3 Assay Panel – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210099

LymphoTrack^® Dx IGH FR2 Assay Panel – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210119

LymphoTrack^® Dx IGH FR3 Assay Panel – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210129

LymphoTrack^® Dx IGH FR1/2/3 Assay Kit A – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210039

LymphoTrack^® Dx IGH FR1 Assay Panel – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: 91210009

LymphoTrack^® Dx IGH FR1 Assay Kit A – MiSeq^TM

The immunoglobulin heavy chain (IGH) gene locus on chromosome 14 (14q32.3) includes 46-52 functional and 30 non-functional variable (VH) gene segments...

View Product

Cat #: S100003

LymphoTrack^® Enterprise Software

The LymphoTrack Enterprise Software package was designed to enable pipeline automation for high-throughput sequencing laboratories using LymphoTrack A...

View Product

Cat #: S100001

IdentiClone^® RUO TCRG 2.0 Software

IdentiClone RUO TCRG 2.0 software is an Research Use Only (RUO) product specifically designed for the analysis of raw FSA files obtained from the ABI ...

View Product

Cat #: K4120331

リューコストラットＣＤｘＦＬＴ３変異検査 (R)

リューコストラットCDx FLT3 変異検査は、日本国内でギルテリチニブフマル酸塩およびキザルチニブ塩酸塩の両方...

View Product

Cat #: K4120431

LeukoStrat^® CDx FLT3 Mutation Assay

Acute myelogenous leukemia (AML) in general has a poor prognosis. Assessment of the mutation status of the FLT3 (fms related tyrosine kinase 3) recept...

View Product

Cat #: S100004

NPM1 MRD Software for Use on Illumina^® MiSeq^TM Platform

The NPM1 MRD Assay for use with the Illumina® MiSeqTM platform was designed to produce sequencing data that can be analyzed using the NPM1 MRD Softwa...

View Product

Cat #: 14160019

NPM1 MRD Assay

BACKGROUND The Nucleophosmin (NPM1) gene encodes for a protein involved in cellular activities that may relate to proliferative and growth-suppressive...

View Product

Cat #: S100005

FLT3 ITD MRD Software for Use on Illumina^® MiSeq^TM Platform

The FLT3 ITD MRD Assay for use with the Illumina® MiSeqTM platform was designed to produce sequencing data that can be analyzed using the FLT3 ITD MR...

View Product

Cat #: 14120019

FLT3 ITD MRD Assay

BACKGROUND Mutations in the fms-like tyrosine kinase 3 (FLT3) gene are the most prevalent mutations found in acute myeloid leukemia (AML) and are char...

View Product

Cat #: 60970130

FalconTaq DNA Polymerase

For highly specific and sensitive amplification using PCR. Obtain high specificity, sensitivity, and yield. Prevent the extension of non-specifically...

View Product

Cat #: K4120361

LeukoStrat^® CDx FLT3 Mutation Assay

The LeukoStrat® CDx FLT3 Mutation Assay is the companion diagnostic to RYDAPT® (midostaurin), XOSPATA® (gilteritinib), and VANFLYTA® (quizartinib)...

View Product

Cat #: 40880108

LymphoTrack^® T-Cell Low Positive Control

The T-cell LymphoQuant Internal Control and T-cell LymphoTrack Low Positive Control are utilized in controlled MRD studies of TRG and TRB gene rearran...

View Product

Cat #: 40880128

LymphoQuant^® T-Cell Internal Control

The T-cell LymphoQuant Internal Control and T-cell LymphoTrack Low Positive Control are utilized in controlled MRD studies of TRG and TRB gene rearran...

View Product

Cat #: 40880118

LymphoQuant^® B-cell Internal Control

LymphoQuant B-cell Internal Controls may be spiked into specimens to estimate the respective number of IGH clonotype equivalents present. Addition o...

View Product

Cat #: 40880098

LymphoTrack^® B-cell Low Positive Control

Minimal Residual Disease (MRD) testing by Next-Generation Sequencing (NGS) is a proven tool in the development of management strategies for hematologi...

View Product

Cat #: 71210149

LymphoTrack^® IGH FR1 Assay Panel B – MiSeq^TM

This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...

View Product

Cat #: 23090060

BCL2/J_H Tube B – Unlabeled for Gel Detection

BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant transcriptional ...

View Product

Cat #: 23090050

BCL2/J_H Tube A – Unlabeled for Gel Detection

BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant transcriptional ...

View Product

Cat #: 13090040

BCL2/J_H Translocation Assay MegaKit for Gel Detection

BACKGROUND BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant trans...

View Product

Cat #: 12070101

T-Cell Receptor Gamma Gene Rearrangement Assay 2.0

BACKGROUND Invivoscribe’s T-Cell Receptor Gamma Gene Rearrangement Assay 2.0 represents an improved approach to PCR-based clonality testing of T-cel...

View Product

Cat #: A3090070

BCL2/J_H mcr – Unlabeled

This product targets the human BCL2/JH fusion gene. ...

View Product

Cat #: 12070051

T-Cell Receptor Gamma Gene Rearrangement Assay for ABI Fluorescence Detection

BACKGROUND Rearrangement of the variable (Vγ) and joining (Jγ) gene segments of the TRG locus results in Vγ-Jγ products of unique length and seque...

View Product

Cat #: A3090050

BCL2/J_H Mbr – Unlabeled

This product targets the human BCL2/JH fusion gene. ...

View Product

Cat #: A3090060

BCL2/J_H 3’Mbr – Unlabeled

This product targets the human BCL2/JH fusion gene. ...

View Product

Cat #: 23080010

BCL1/J_H Tube – Unlabeled for Gel Detection

The aberrant BCL1/JH t(11;14) translocation juxtaposes genes of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32 with the cyclin D1 gene ...

View Product

Cat #: 13080020

BCL1/JH Translocation Assay MegaKit for Gel Detection

BACKGROUND This aberrant BCL1/JH t(11;14) translocation juxtaposes genes of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32 with the cyc...

View Product

Cat #: 40880008

IGH SHM Positive Control DNA

This DNA control is adjusted to a final concentration of 15 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient b...

View Product

Cat #: 92070101

IdentiClone^® T-cell Receptor Gamma Gene Rearrangement Assay 2.0 – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes and generate products that are unique in length and sequence...

View Product

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing